As of Jul 07
| -0.12 / -9.38%|
The 1 analysts offering 12-month price forecasts for Nymox Pharmaceutical Corp have a median target of 9.00, with a high estimate of 9.00 and a low estimate of 9.00. The median estimate represents a +675.86% increase from the last price of 1.16.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.